Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Resuscitation in Pediatric Burn Patients
NCT06224777Phase 3Completed
- Sponsor
- King Edward Medical University
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of albumin (human) in burn injury, sponsored by King Edward Medical University. Primary endpoint: Resuscitation Volume. Started Jan 2022; status: completed.
02
Drugs
albumin (human)
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT06224777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06224777.